Jie Jin

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 89

Top Topics

Acute Myeloid Leukemia

Newly Diagnosed

Top Venues

British journal of haematology

American journal of hematology

Journal of translational medicine

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiang Zhang, Yi Zhong, Lixia Liu, Shanshan Suo, Shuqi Zhao, Feng Xiao, Jia-Yue Qin, Hong-Yan Tong, Jie Jin, Wenjuan Yu
MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report. British journal of haematology (2024)
Jiajia Pan, Yungui Wang, Shujuan Huang, Shihui Mao, Qing Ling, Chenying Li, Fenglin Li, Mengxia Yu, Xin Huang, Jiansong Huang, Yunfei Lv, Xia Li, Wenle Ye, Huafeng Wang, Jinghan Wang, Jie Jin
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of molecular medicine (Berlin, Germany) 102 (3) (2024)
Shuqi Zhao, Jinghan Wang, Yinjun Lou, Xin Huang, Wanzhuo Xie, Wenjuan Yu, Lin Liu, Yijing Zhu, Xiangli Gao, Guanghua Ma, Ziyang Zhou, Ehsan Ghoushi, Mohammadyousof Ghafouri, Jie Jin, Hong-Yan Tong, De Zhou
Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study. British journal of haematology (2024)
Ziyue Zhou, Nanfang Zhuo, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Peifeng Pan, Hong-Yan Tong, Jie Jin, Huafeng Wang
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. American journal of hematology 99 (7) (2024)
Jiajia Pan, Yungui Wang, Shujuan Huang, Shihui Mao, Qing Ling, Chenying Li, Fenglin Li, Mengxia Yu, Xin Huang, Jiansong Huang, Yunfei Lv, Xia Li, Wenle Ye, Huafeng Wang, Jinghan Wang, Jie Jin
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of molecular medicine (Berlin, Germany) 102 (3) (2024)
Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hong-Yan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Yanchun Zhao, Yutong Zhou, Yu Qian, Wenwen Wei, Xiangjie Lin, Shihui Mao, Jie Sun, Jie Jin
m 6 A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clinical and translational medicine 14 (4) (2024)
Jie Jin, Hong Cen, Ke-Shu Zhou, Xiaohong Xu, Fei Li, Tao Wu, Haiyan Yang, Zhen Wang, Zhi-Ming Li, Wenyang Huang, Hanying Bao, Zusheng Xu, Lugui Qiu
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hong-Yan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Ziyue Zhou, Nanfang Zhuo, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Peifeng Pan, Hong-Yan Tong, Jie Jin, Huafeng Wang
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. American journal of hematology (2024)
Peipei Ye, Yixuan Cheng, Jiaying Lian, Hong-Yan Tong, Linjie Li, Qunyi Guo, Weiguo Zhu, Weiying Feng, Li Huang, Lihong Shou, Dong Chen, Xuhui Liu, Shuangyue Li, Xiaohong Du, Min Yang, Wenjuan Yu, Jiejing Qian, Chao Hu, Huafeng Wang, Yangjin Jin, Jian Shen, Pan Hong, Renzhi Pei, Jie Jin, Ying Lu
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study. British journal of haematology (2024)
Rong Wang, Yi Zhang, Jie Chang, Huafeng Wang, Yinjun Lou, Min Yang, Gaixiang Xu, Hongyan Tong, Wanzhuo Xie, De Zhou, Juying Wei, Wenyuan Mai, Xiu-Jin Ye, Haitao Meng, Jie Jin, Hong Hu Zhu
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis. Hematological oncology 42 (2) (2024)
Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hong-Yan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Ziyue Zhou, Nanfang Zhuo, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Peifeng Pan, Hong-Yan Tong, Jie Jin, Huafeng Wang
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. American journal of hematology 99 (7) (2024)
Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hong-Yan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology (2024)
Yanchun Zhao, Yutong Zhou, Yu Qian, Wenwen Wei, Xiangjie Lin, Shihui Mao, Jie Sun, Jie Jin
m 6 A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clinical and translational medicine 14 (4) (2024)
Xiang Zhang, Yi Zhong, Lixia Liu, Shanshan Suo, Shuqi Zhao, Feng Xiao, Jia-Yue Qin, Hong-Yan Tong, Jie Jin, Wenjuan Yu
MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report. British journal of haematology 205 (1) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Peipei Ye, Yixuan Cheng, Jiaying Lian, Hong-Yan Tong, Linjie Li, Qunyi Guo, Weiguo Zhu, Weiying Feng, Li Huang, Lihong Shou, Dong Chen, Xuhui Liu, Shuangyue Li, Xiaohong Du, Min Yang, Wenjuan Yu, Jiejing Qian, Chao Hu, Huafeng Wang, Yangjin Jin, Jian Shen, Pan Hong, Renzhi Pei, Jie Jin, Ying Lu
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study. British journal of haematology 204 (6) (2024)
Lingxu Jiang, Yudi Zhang, Jiejing Qian, Xinping Zhou, Liya Ma, Shuanghong Zhu, Lu Wang, Wei Wang, Wenli Yang, Yingwan Luo, Wei Lang, Gaixiang Xu, Yanling Ren, Chen Mei, Li Ye, Qi Zhang, Xiaozhen Liu, Jie Jin, Jie Sun, Hong-Yan Tong
The m 6 A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms. Leukemia (2024)
Jiajia Pan, Yungui Wang, Shujuan Huang, Shihui Mao, Qing Ling, Chenying Li, Fenglin Li, Mengxia Yu, Xin Huang, Jiansong Huang, Yunfei Lv, Xia Li, Wenle Ye, Huafeng Wang, Jinghan Wang, Jie Jin
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of molecular medicine (Berlin, Germany) (2024)
Jiajia Pan, Yungui Wang, Shujuan Huang, Shihui Mao, Qing Ling, Chenying Li, Fenglin Li, Mengxia Yu, Xin Huang, Jiansong Huang, Yunfei Lv, Xia Li, Wenle Ye, Huafeng Wang, Jinghan Wang, Jie Jin
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response. Journal of molecular medicine (Berlin, Germany) 102 (3) (2024)
Ziyue Zhou, Nanfang Zhuo, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Peifeng Pan, Hong-Yan Tong, Jie Jin, Huafeng Wang
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients. American journal of hematology 99 (7) (2024)
Yanchun Zhao, Yutong Zhou, Yu Qian, Wenwen Wei, Xiangjie Lin, Shihui Mao, Jie Sun, Jie Jin
m 6 A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clinical and translational medicine 14 (4) (2024)
Yanchun Zhao, Yutong Zhou, Yu Qian, Wenwen Wei, Xiangjie Lin, Shihui Mao, Jie Sun, Jie Jin
m 6 A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clinical and translational medicine 14 (4) (2024)
Peipei Ye, Yixuan Cheng, Jiaying Lian, Hong-Yan Tong, Linjie Li, Qunyi Guo, Weiguo Zhu, Weiying Feng, Li Huang, Lihong Shou, Dong Chen, Xuhui Liu, Shuangyue Li, Xiaohong Du, Min Yang, Wenjuan Yu, Jiejing Qian, Chao Hu, Huafeng Wang, Yangjin Jin, Jian Shen, Pan Hong, Renzhi Pei, Jie Jin, Ying Lu
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study. British journal of haematology 204 (6) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Yi Zhang, Hu Zhou, Ming-Hui Duan, Sujun Gao, Guang-Sheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huan-Ling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei Wang, Na Xu, Haiping Yang, Binhua Lu, Hewen Yin, Liqing Wu, Shanshan Suo, Qingwei Zhao, Zhijian Xiao, Jie Jin
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study. American journal of hematology (2023)
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Chao Hu, Mengjing Li, Jie Sun, Jie Jin
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of hematology 102 (3) (2023)
Zhixin Ma, Wenle Ye, Jinghan Wang, Xin Huang, Jiansong Huang, Xia Li, Chao Hu, Chenying Li, Yile Zhou, Xiangjie Lin, Wenwen Wei, Yu Qian, Yutong Zhou, Shihui Mao, Xiufeng Yin, Bo Zhu, Jie Jin
Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. British journal of haematology (2023)
Xuejiao Yin, Yi Liu, Chengli Zhong, Yunfei Lv, Dan Xu, Li Zhu, Jie Jin, Haitao Meng, Liang-Shun You
Rituximab-bortezomib-dexamethasone induce high response rates in iMCD in clinical practice. British journal of haematology (2023)
Mixue Xie, Ting Shi, Qi Jiang, Yunlu Jia, De Zhou, Hongyan Tong, Jie Jin, Hong Hu Zhu
Chemotherapy with the use of next-generation TKIs based on MRD has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer (2023)
Fenglin Li, Wenle Ye, Yiyi Yao, Wenwen Wei, Xiangjie Lin, Haihui Zhuang, Chenying Li, Xia Li, Qing Ling, Chao Hu, Xin Huang, Yu Qian, Shihui Mao, Jiansong Huang, Ying Lu, Jie Jin
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. Journal of translational medicine 21 (1) (2023)
Fenglin Li, Wenle Ye, Yiyi Yao, Wenwen Wei, Xiangjie Lin, Haihui Zhuang, Chenying Li, Xia Li, Qing Ling, Chao Hu, Xin Huang, Yu Qian, Shihui Mao, Jiansong Huang, Ying Lu, Jie Jin
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. Journal of translational medicine 21 (1) (2023)
Peter Hokland, Isolda I Fernández, Sylvie D Freeman, Bjorn Tore Gjertsen, Jie Jin, Vidh Murthy, Masamitsu Yanada, Arnold Ganser
AML in the elderly-A global view. British journal of haematology (2023)
Fenglin Li, Qing Ling, Jiaying Lian, Ying Chen, Chao Hu, Min Yang, Xiang Zhang, Chenying Li, Shihui Mao, Wenle Ye, Xia Li, Xiangjie Lin, Wenwen Wei, Xin Huang, Jiajia Pan, Yu Qian, Jinghan Wang, Ying Lu, Jie Jin
Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer medicine (2023)
Liang-Shun You, Yi Liu, Nianci Chen, Li Zhu, Gaixiang Xu, Zuopo Lv, Yile Zhou, Chenying Li, Hongyan Tong, Jie Jin, Haitao Meng
Influenza A (H1N1) virus induced long-term remission in a refractory acute myeloid leukaemia. British journal of haematology (2023)
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Chao Hu, Mengjing Li, Jie Sun, Jie Jin
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of hematology 102 (3) (2023)
Fenglin Li, Wenle Ye, Yiyi Yao, Wenwen Wei, Xiangjie Lin, Haihui Zhuang, Chenying Li, Xia Li, Qing Ling, Chao Hu, Xin Huang, Yu Qian, Shihui Mao, Jiansong Huang, Ying Lu, Jie Jin
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. Journal of translational medicine 21 (1) (2023)
Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Li Huang, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hong-Yan Tong, Jie Jin, Huafeng Wang
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia. British journal of haematology (2023)
Xianbo Huang, Shasha Wang, Chen Mei, Yu Xu, Xianhui Wu, Fengwei Du, Yanling Ren, Jie Jin, Hongyan Tong, Jiejing Qian
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report. Annals of hematology (2023)
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming Li, Yuqin Song, Li Zhang, Xiaojian Zhu, Huijing Wu, Wei Zhang, Junmin Li, Ke-Shu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zhenjiang Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Jiaying Wu, Xin Huang, Yungui Wang, Huan Xu, Shuanghong Zhu, Hong Hu Zhu, Jie Jin
Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis. British journal of haematology (2023)
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Chao Hu, Mengjing Li, Jie Sun, Jie Jin
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of hematology (2023)
Xiang Zhang, Ziwei Wang, Jiewen Sun, Lixia Liu, Jia-Yue Qin, Aijie Huang, Min Yang, Yinjun Lou, Gusheng Tang, Liping Mao, Jiejin Qian, Juying Wei, Wenyuan Mai, Haitao Meng, Jian-Min Yang, Hongyan Tong, Jianmin Wang, Wenjuan Yu, Xiong Ni, Jie Jin
New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia. British journal of haematology (2023)
Wenwen Wei, Jiajia Pan, Jinghan Wang, Shihui Mao, Yu Qian, Xiangjie Lin, Qing Ling, Wenle Ye, Yutong Zhou, Yanchun Zhao, Jiansong Huang, Xin Huang, Zhixin Ma, Huanping Wang, Chenying Li, Jie Sun, Jie Jin
circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis. Molecular carcinogenesis (2023)
Fenglin Li, Wenle Ye, Yiyi Yao, Wenwen Wei, Xiangjie Lin, Haihui Zhuang, Chenying Li, Xia Li, Qing Ling, Chao Hu, Xin Huang, Yu Qian, Shihui Mao, Jiansong Huang, Ying Lu, Jie Jin
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis. Journal of translational medicine 21 (1) (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Jie Jin, Albert Qin, Lei Zhang, Weihong Shen, Wei Wang, Jingjing Zhang, Yaning Li, Daoxiang Wu, Zhijian Xiao
A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia vera. Future oncology (London, England) (2023)
Yi Liu, Li Zhu, Zuopo Lv, Liping Mao, Chao Hu, Jinghan Wang, Yile Zhou, Jie Jin, Haitao Meng, Liang-Shun You
Venetoclax plus azacitidine and LDAC induced high response rates in acute myeloid leukaemia in routine clinical practice. British journal of haematology (2023)
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Chao Hu, Mengjing Li, Jie Sun, Jie Jin
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of hematology 102 (3) (2023)
Shihui Mao, Yu Qian, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Chao Hu, Mengjing Li, Jie Sun, Jie Jin
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of hematology 102 (3) (2023)
De Zhou, Xianbo Huang, Mixue Xie, Lixia Zhu, Xin Huang, Xue-Ying Li, Xiudi Yang, Li Li, Jingjing Zhu, Xiaolong Zheng, Jianai Sun, Shuqi Zhao, Wenjuan Yu, Wanzhuo Xie, Hong-Yan Tong, Jie Jin, Hong Hu Zhu, Xiu-Jin Ye
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial. American journal of hematology (2023)
Yi Zhang, Qike Zhang, Qingchi Liu, Huibing Dang, Sujun Gao, Wei Wang, Hu Zhou, Yuqing Chen, Liangming Ma, Jishi Wang, Haiping Yang, Binhua Lu, Hewen Yin, Liqing Wu, Shanshan Suo, Qingwei Zhao, Hongyan Tong, Jie Jin
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study. American journal of hematology (2023)
Yu Qian, Xiang Zhang, Shihui Mao, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Hongyan Tong, Jie Sun, Jie Jin
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD. Molecular oncology (2022)
Chen Mei, Li Ye, Yanling Ren, Xinping Zhou, Liya Ma, Gaixiang Xu, Weilai Xu, Chenxi Lu, Haiyang Yang, Yingwan Luo, Lingxu Jiang, Wei Lang, HongHu Zhu, Jie Jin, Hongyan Tong
15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study. Hematological oncology (2022)
Fenglin Li, Qing Ling, Chao Hu, Huafeng Wang, Wenle Ye, Xia Li, Xiang Zhang, Xiangjie Lin, Wenwen Wei, Xin Huang, Yu Qian, Haihui Zhuang, Jie Jin, Ying Lu
Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance. Journal of oncology 2022 (2022)
Huafeng Wang, Jie Sun, Bin Zhang, Dandan Zhao, Hongyan Tong, Herman Wu, Xia Li, Yingwan Luo, Dan Dong, Yiyi Yao, Tinisha McDonald, Anthony S Stein, Monzr M Al Malki, Flavia Pichiorri, Nadia Carlesso, Ya-Huei Kuo, Guido Marcucci, Ling Li, Jie Jin
Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells. Clinical and translational medicine 11 (10) (2022)
Chen Mei, Li Ye, Yanling Ren, Xinping Zhou, Liya Ma, Gaixiang Xu, Weilai Xu, Chenxi Lu, Haiyang Yang, Yingwan Luo, Lingxu Jiang, Wei Lang, HongHu Zhu, Jie Jin, Hongyan Tong
15-days duration of Venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study. Hematological oncology (2022)
Qian Qian Wang, Hua-Feng Wang, Jian-Zhi Zhao, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax for arsenic-resistant acute promyelocytic leukaemia. British journal of haematology 197 (5) (2022)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Wenjuan Yu, Jie Jin
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. American journal of hematology 97 (12) (2022)
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong Hu Zhu
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia. Blood cancer journal 12 (1) (2022)
Wenwen Wei, Shujuan Huang, Qing Ling, Shihui Mao, Yu Qian, Wenle Ye, Fenglin Li, Jiajia Pan, Xiangjie Lin, Jiansong Huang, Xin Huang, Yifan Zhai, Jie Sun, Jie Jin
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia. Journal of translational medicine 20 (1) (2022)
Yu Qian, Xiang Zhang, Shihui Mao, Wenwen Wei, Xiangjie Lin, Qing Ling, Wenle Ye, Fenglin Li, Jiajia Pan, Yutong Zhou, Yanchun Zhao, Xin Huang, Jiansong Huang, Hongyan Tong, Jie Sun, Jie Jin
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD. Molecular oncology (2022)
Xiang Zhang, Jiewen Sun, Wenjuan Yu, Jie Jin
Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomarker research 9 (1) (2021)
Huan-Ping Wang, Yile Zhou, Xin Huang, Yi Zhang, Jiejing Qian, Jianhu Li, Chenying Li, Xue-Ying Li, Yinjun Lou, Qiaoyun Zhu, Yujie Huang, Haitao Meng, Wenjuan Yu, Hong-Yan Tong, Jie Jin, Hong-Hu Zhu
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia. British journal of haematology 193 (6) (2021)
Xuefen Yan, Lu Wang, Lingxu Jiang, Yingwan Luo, Peipei Lin, Wenli Yang, Yanling Ren, Liya Ma, Xinping Zhou, Chen Mei, Li Ye, Gaixiang Xu, Weilai Xu, Haiyang Yang, Chenxi Lu, Jie Jin, Hong-Yan Tong
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 10 (5) (2021)
Liya Ma, Lingxu Jiang, Wenli Yang, Yingwan Luo, Chen Mei, Xinping Zhou, Gaixiang Xu, Weilai Xu, Li Ye, Yanling Ren, Chenxi Lu, Peipei Lin, Jie Jin, Hong-Yan Tong
Real-world data of chronic myelomonocytic leukemia: A chinese single-center retrospective study. Cancer medicine 10 (5) (2021)
Shihui Mao, Qing Ling, Jiajia Pan, Fenglin Li, Shujuan Huang, Wenle Ye, Wenwen Wei, Xiangjie Lin, Yu Qian, Yungui Wang, Xin Huang, Jiansong Huang, Jinghan Wang, Jie Jin
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199. Journal of translational medicine 19 (1) (2021)
Jie-Jing Qian, Xiaoxia Hu, Ying Wang, Yi Zhang, Juan Du, Min Yang, Hongyan Tong, Wen-Bin Qian, Juying Wei, Wenjun Yu, Yin-Jun Lou, Liping Mao, Hai Tao Meng, Liang-Shun You, Libing Wang, Xia Li, Xin Huang, Li-Hong Cao, Jian-Zhi Zhao, Xiao Yan Yan, Yu-Bao Chen, Yu Chen, Su-Jiang Zhang, Jie Jin, Jiong Hu, Hong Hu Zhu
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study. Cancer medicine 9 (15) (2020)
Hong Hu Zhu, Meng-Cheng Yang, Feng Wang, Yin-Jun Lou, Jie Jin, Ke Li, Shi-Zhong Zhang
Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia. American journal of hematology 95 (7) (2020)
JingHan Wang, Xingnong Ye, Cuihua Fan, Jie Zhou, Shuna Luo, Jingxia Jin, Dan Chen, Yan Zheng, Cai Wu, Xiaoqiong Zhu, Jie Jin, Jian Huang
Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML. Biomarker research 8 (1) (2020)
Jiansong Huang, Shujuan Huang, Zhixin Ma, Xiangjie Lin, Xia Li, Xin Huang, Jinghan Wang, Wenle Ye, Yang Li, Daqiang He, Min Yang, Jiajia Pan, Qing Ling, Fenglin Li, Shihui Mao, Huafeng Wang, Yungui Wang, Jie Jin
Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation. Thrombosis and haemostasis 121 (2) (2020)
Xiang Zhang, Shanshan Suo, Jinghan Wang, Jie Jin, Wenjuan Yu
IDH1R132S -mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC. British journal of haematology 192 (2) (2020)
Huan-Ping Wang, Yi-Le Zhou, Xin Huang, Yi Zhang, Jie-Jing Qian, Jian-Hu Li, Xue-Ying Li, Chen-Ying Li, Yin-Jun Lou, Wen-Yuan Mai, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Jie Jin, Hong Hu Zhu
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia. American journal of hematology 96 (3) (2020)
Shujuan Huang, Chenying Li, Xiang Zhang, Jiajia Pan, Fenglin Li, Yunfei Lv, Jingwen Huang, Qing Ling, Wenle Ye, Shihui Mao, Xin Huang, Jie Jin
Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner. Molecular oncology 14 (10) (2020)
Yi Zhang, Shan-Shan Suo, Han-Jin Yang, Xin-Ping Zhou, Liang-Shun You, Wen-Juan Yu, Zhao-Ming Wang, Jie Jin
Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study. Journal of cancer research and clinical oncology 146 (2) (2020)
Xue-Ying Li, Jie-Jing Qian, Min Yang, Yi Zhang, Sha-Sha Wang, Hai-Tao Meng, Wen-Juan Yu, Hong-Yan Tong, Xiu-Jin Ye, Jie Jin, Hong-Hu Zhu
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. British journal of haematology 189 (6) (2020)
Hong Hu Zhu, Jie-Jing Qian, Wan-Jun Sun, Liang-Shun You, Qian Qian Wang, Hua Naranmandura, Jie Jin
Venetoclax and arsenic showed synergistic anti-leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation. American journal of hematology 95 (3) (2020)
Mengxia Yu, Chenying Li, Chao Hu, Jingrui Jin, Shenxian Qian, Jie Jin
The relationship between consumption of nitrite or nitrate and risk of non-Hodgkin lymphoma. Scientific reports 10 (1) (2020)
Jingrui Jin, Shihui Mao, Fenglin Li, Xia Li, Xin Huang, Mengxia Yu, Wenjian Guo, Jie Jin
A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells. Medical oncology (Northwood, London, England) 36 (9) (2019)
Lingxu Jiang, Yingwan Luo, Shuanghong Zhu, Lu Wang, Liya Ma, Hua Zhang, Chuying Shen, Wenli Yang, Yanling Ren, Xinping Zhou, Chen Mei, Li Ye, Weilai Xu, Haiyang Yang, Chenxi Lu, Jie Jin, Hong-Yan Tong
Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 111 (2) (2019)
Jiansong Huang, Xia Li, Xiaofeng Shi, Mark Zhu, Jinghan Wang, Shujuan Huang, Xin Huang, Huafeng Wang, Ling Li, Huan Deng, Yulan Zhou, Jianhua Mao, Zhangbiao Long, Zhixin Ma, Wenle Ye, Jiajia Pan, Xiaodong Xi, Jie Jin
Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting. Journal of hematology & oncology 12 (1) (2019)
Hong Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin
The simpler, the better: oral arsenic for acute promyelocytic leukemia. Blood 134 (7) (2019)
Jinghan Wang, Wenle Ye, Xiao Yan, Qi Guo, Qiuling Ma, Fang Lin, Jiansong Huang, Jie Jin
Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia. Journal of translational medicine 17 (1) (2019)
Xiao Yan, Yile Zhou, Shujuan Huang, Xia Li, Mengxia Yu, Jiansong Huang, Jinghan Wang, Zhixin Ma, Jingrui Jin, Jiajia Pan, Chenying Li, Fenglin Li, Jie Jin
Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma. Journal of cancer research and clinical oncology 144 (4) (2018)
Jinghan Wang, Zhixin Ma, Qinrong Wang, Qi Guo, Jiansong Huang, Wenjuan Yu, Huanping Wang, Jingwen Huang, Yang Washington Shao, Suning Chen, Jie Jin
Prognostic utility of six mutated genes for older patients with acute myeloid leukemia. International journal of cancer 142 (8) (2017)